Hong, J., Novick, D., Brugnoli, R., Karagianis, J., Dossenbach, M., & Haro, J. M. (2012). Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study. BioMed Central.
Styl cytowania ChicagoHong, Jihyung, Diego Novick, Roberto Brugnoli, Jamie Karagianis, Martin Dossenbach, i Josep Maria Haro. Clinical Consequences of Switching From Olanzapine to Risperidone and Vice Versa in Outpatients With Schizophrenia: 36-month Results From the Worldwide Schizophrenia Outpatients Health Outcomes (W-SOHO) Study. BioMed Central, 2012.
Styl cytowania MLAHong, Jihyung, et al. Clinical Consequences of Switching From Olanzapine to Risperidone and Vice Versa in Outpatients With Schizophrenia: 36-month Results From the Worldwide Schizophrenia Outpatients Health Outcomes (W-SOHO) Study. BioMed Central, 2012.